Douglas S. Harrington
- Oncology top 5%
- Pathology and Forensic Medicine top 2%
- Cancer Research top 10%
- Immunology top 10%
- Molecular Biology
- Co-authors
- K. BloomJamés O. ArmitageDennis D. WeisenburgerDavid T. PurtiloWarren G. SangerJ LinderD D WeisenburgerSonny L. Johansson
- Topics
- Lymphoma Diagnosis and Treatment (13 papers)Viral-associated cancers and disorders (8 papers)Chronic Lymphocytic Leukemia Research (7 papers)
- Partner nations
- United StatesSwedenSerbia
In The Last Decade
Douglas S. Harrington
35 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Oncology 694
- Pathology and Forensic Medicine 500
- Cancer Research 306
- Immunology 243
- Molecular Biology 210
Countries citing papers authored by Douglas S. Harrington
This map shows the geographic impact of Douglas S. Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Harrington more than expected).
Fields of papers citing papers by Douglas S. Harrington
This network shows the impact of papers produced by Douglas S. Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Harrington. The network helps show where Douglas S. Harrington may publish in the future.
Co-authorship network of co-authors of Douglas S. Harrington
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas S. Harrington. A scholar is included among the top collaborators of Douglas S. Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas S. Harrington. Douglas S. Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 15 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 82 | |
| 7 | 16 | |
| 8 | 123 | |
| 9 | 65 | |
| 10 | 13 | |
| 11 | 51 | |
| 12 | 0 | |
| 13 | 64 | |
| 14 | 25 | |
| 15 | 43 | |
| 16 | 71 | |
| 17 | 36 | |
| 18 | 28 | |
| 19 | Bone marrow necrosis obscuring the diagnosis of acute promyelocytic leukemia. | 9 |
| 20 | 8 |
About Douglas S. Harrington
Douglas S. Harrington is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Viral-associated cancers and disorders (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (500 citations), Oncology (694 citations) and Cancer Research (306 citations). Douglas S. Harrington has collaborated with scholars based in United States, Sweden and Serbia. Frequent co-authors include K. Bloom, Jamés O. Armitage, Dennis D. Weisenburger, David T. Purtilo, Warren G. Sanger, J Linder, D D Weisenburger, Sonny L. Johansson, Magnus Fall and Blaise Bossy. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.